Found: 3
Select item for more details and to access through your institution.
MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, doubleblind, placebo-controlled study incorporating pharmacodynamic biomarker assessments.
- Published in:
- Arthritis Research & Therapy, 2011, v. 13, n. 5, p. 1, doi. 10.1186/ar3502
- By:
- Publication type:
- Article
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells.
- Published in:
- Nature Immunology, 2009, v. 10, n. 1, p. 48, doi. 10.1038/ni.1674
- By:
- Publication type:
- Article
Tumour and host cell PD-L1 is required to mediate suppression of anti-tumour immunity in mice.
- Published in:
- Nature Communications, 2017, v. 8, n. 2, p. 14572, doi. 10.1038/ncomms14572
- By:
- Publication type:
- Article